Omega Fund Management’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History

Omega Fund Management’s Portfolio THRX Stock Details THRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-711,479	Closed	-$2.88M	–	14
2023 Q4	$2.88M	Hold	711,479	–	–	2.33%	10
2023 Q3	$1.91M	Hold	711,479	–	–	1.76%	9
2023 Q2	$6.64M	Hold	711,479	–	–	3.72%	6
2023 Q1	$6.32M	Hold	711,479	–	–	4.12%	6
2022 Q4	$3.54M	Hold	711,479	–	–	1.19%	10
2022 Q3	$4.13M	Hold	711,479	–	–	1.51%	14
2022 Q2	$3.93M	Hold	711,479	–	–	1.26%	14
2022 Q1	$8.2M	Hold	711,479	–	–	1.68%	12
2021 Q4	$9.02M	Buy	+711,479	New	+$10.7M	1.28%	14

Omega Fund Management's THRX Position: Q1 2024 in Review

Omega Fund Management sold out of Theseus Pharmaceuticals, Inc. Common Stock (THRX) in Q1 2024, closing a stake of 711,479 shares — an estimated $2.88M sold.

Omega Fund Management first reported a position in THRX in Q4 2021 and held it in 9 quarters. The position peaked at $9.02M in Q4 2021. 1 fund tracked by Wall St. Rank holds THRX as of Q1 2024.

Omega Fund Management reported no remaining Theseus Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Omega Fund Management sold 711,479 Theseus Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $2.88M.
Omega Fund Management first reported a position in Theseus Pharmaceuticals, Inc. Common Stock in Q4 2021 and held it in 9 quarters.
Omega Fund Management's Theseus Pharmaceuticals, Inc. Common Stock position peaked at $9.02M in Q4 2021.
1 fund tracked by Wall St. Rank held Theseus Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on Omega Fund Management's 13F filing for Q1 2024, filed 14 May 2024.